This is the authors' abstract. We don't add key points for this paper.
32 patients with chronic postprandial dyspepsia were selected for a 4-week controlled double-blind trial of domperidone and a placebo. The patients received either domperidone or a placebo at a dose rate of two 10-mg tablets t.i.d. before meals. A questionnaire was completed at the start of the study, and after 2 and 4 weeks of treatment. Excellent or good improvement was obtained in 71% of the domperidone-treated patients compared to only 13% of the placebo-treated cases. Domperidone was also significantly superior to the placebo when both drugs were compared to previously used medications. Side effects were not reported. It is concluded that domperidone has a beneficial effect on chronic postprandial dyspepsia.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Rutgeerts et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: